Pauline Wils

Olmesartan-associated enteropathy: results of a national survey

Lysiane Marthey, Guillaume Cadiot, Philippe Seksik et al. · Alimentary Pharmacology & Therapeutics · 2014 · 198 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn’s Disease Refractory to Anti–Tumor Necrosis Factor Agents

Pauline Wils, Yoram Bouhnik, Pierre Michetti et al. · Clinical Gastroenterology and Hepatology · 2015 · 171 citations · Full text

Veterinary Medicine, Clinical Sciences, Pharmacotherapy +12

Long‐term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience

Pauline Wils, Yoram Bouhnik, Pierre Michetti et al. · Alimentary Pharmacology & Therapeutics · 2018 · 101 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Diseases: the REMSWITCH Study

Anthony Buisson, Maria Nachury, Maud Reymond et al. · Clinical Gastroenterology and Hepatology · 2022 · 88 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +13

Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study

Pauline Wils, Philippe Seksik, Carmen Stefănescu et al. · Alimentary Pharmacology & Therapeutics · 2020 · 77 citations

Medicine, Immunology, Pharmacotherapy +17